Narrow Results By
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
https://policybase.cma.ca/link/policy11114
Proposed amendments to the marihuana for medical purposes regulations
https://policybase.cma.ca/link/policy11293
Tamper Resistance under the Controlled Drugs and Substances Act
https://policybase.cma.ca/link/policy11295
- Date
- 2014-08-26
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)
https://policybase.cma.ca/link/policy11599
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/link/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/link/policy11847
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/link/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Legalization, regulation and restriction of access to marijuana
https://policybase.cma.ca/link/policy11954
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/link/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Consultation on the renewal of Federal Tobacco Control Strategy
https://policybase.cma.ca/link/policy13804
- Date
- 2017-04-05
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Federal Monitoring and Reporting Regime for MAID
https://policybase.cma.ca/link/policy13853
CMA response to patented medicines regulations consultations
https://policybase.cma.ca/link/policy13690
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/link/policy13734
Excise duty framework for cannabis products
https://policybase.cma.ca/link/policy13799
Proposed approach to the regulation of cannabis
https://policybase.cma.ca/link/policy13838
Federal monitoring of medical assistance in dying regulations
https://policybase.cma.ca/link/policy13856
Consultation on proposed front-of-package labelling
https://policybase.cma.ca/link/policy13882
- Date
- 2018-04-23
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Health Canada consultation on restriction of marketing and advertising of opioids
https://policybase.cma.ca/link/policy13921
Health Canada consultation on regulatory amendments regarding tramadol
https://policybase.cma.ca/link/policy13927
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
https://policybase.cma.ca/link/policy13930
- Date
- 2018-09-06
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs